1. Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire 
Erick Xavier, Jérôme Cornillon, Annalisa Ruggeri, Patrice Chevallier, Jan J. Cornelissen, Niels S. Andersen, Natacha Maillard, Stephanie Nguyen, Didier Blaise, Eric Deconinck, Hendrik Veelken, Noel Milpied, Michel Van Gelder, Regis Peffault de Latour, Eliane Gluckman, Nicolaus Kröger, Johannes Schetelig, Vanderson Rocha 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 8, Pages (August 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) NRM according to fludarabine sensitivity (straight line represents fludarabine-refractory CLL/SLL and dotted line represents fludarabine-sensitive CLL/SLL). (B) NRM according to the number of previous lines of chemotherapy (straight line represents patients who received ≥3 lines of chemotherapy and dotted represents ≤2 lines of chemotherapy before UCBT).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2 PFS according to del 17p/p53mutations status.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
(A) Overall PFS from the entire cohort of patients. (B) PFS according to fludarabine sensitivity.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions